entinostat has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahmani, M | 1 |
| Yu, C | 1 |
| Reese, E | 1 |
| Ahmed, W | 1 |
| Hirsch, K | 1 |
| Dent, P | 1 |
| Grant, S | 1 |
1 other study available for entinostat and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Inhibition of PI-3 kinase sensitizes human leukemic cells to histone deacetylase inhibitor-mediated apoptosis through p44/42 MAP kinase inactivation and abrogation of p21(CIP1/WAF1) induction rather than AKT inhibition.
Topics: Apoptosis; Benzamides; Butyrates; Chromones; Complement Membrane Attack Complex; Complement System P | 2003 |